27 May 2024 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

• Apadamtase alfa
• Paclitaxel
• Bevacizumab
• Sugemalimab
• Dasatinib monohydrate
• Fidanacogene elaparvovec
• Influenza vaccine
• Germanium (68 Ge) chloride/Gallium (68 Ga) chloride
• Chikungunya virus vaccine (live, attenuated)
• Pomalidomide
• Dasiglucagon

Read CHMP agenda